Market Overview

Hypertension Forecast In 19 Major Markets 2018-2028 by Gender & 5 Year Age Cohort

Share:

Dublin, Aug. 08, 2018 (GLOBE NEWSWIRE) -- The "Hypertension Forecast In 19 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Hypertension (high blood pressure) is a common condition in which the force of the blood against the artery walls is high enough that it may eventually cause serious health problems. These health problems include heart attack, stroke, chronic kidney disease and heart failure.

This report provides the current prevalent population for Hypertension across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team , several of the main symptoms and co-morbidities of Hypertension have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Hypertension include:

  • Chronic heart failure
  • Chronic kidney disease
  • Myocardial infarction
  • Ischaemic heart disease
  • Stroke
  • Diabetes
  • Metabolic syndrome

Reasons to buy

  • Ability to quantify patient populations in global Hypertension market to target the development of future products, pricing strategies and launch plans.
  • Further insight into the prevalence of the subdivided types of Hypertension and identification of patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Better understanding on the impact of specific co-morbid conditions on the prevalent population of Hypertension patients.
  • Identification of Hypertension patient sub-populations that require treatment.
  • Better understanding of the specific markets that have the largest number of Hypertension patients.

Key Topics Covered

  1. List of Tables and Figures
  2. Introduction
  3. Cause Of The Disease
  4. Risk Factors & Prevention
  5. Diagnosis Of The Disease
  6. Variation By Geography/Ethnicity
  7. Disease Prognosis & Clinical Course
  8. Key Comorbid Conditions / Features Associated With The Disease
  9. Methodology For Quantification Of Patient Numbers
  10. Top-Line Prevalence For Hypertension
  11. Features Of Hypertension Patients
  12. Comorbidities Of Hypertension Patients
  13. Abbreviations Used In The Report
  14. Other Publisher Services & Solutions
  15. Reports & Publications
  16. Online Epidemiology Databases
  17. Online Pharmaceutical Pricing Database
  18. References
  19. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/t5s6c6/hypertension?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs 

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
MOSJP MorganDowngrades33.0
BACKeefe Bruyette & WoodsDowngrades29.0
AMTMorgan StanleyDowngrades170.0
EBAYMorgan StanleyDowngrades33.0
UNITMorgan StanleyDowngrades16.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.